Concepedia

Chie-Schin Shih

CS

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

2006

Affiliations

Yonsei University(Current)

Indiana University – Purdue University Indianapolis

Merck & Co., Inc., Rahway, NJ, USA (United States)

National Cancer Center Hospital East

KU Leuven

Chie-Schin Shih is an author at Yonsei University specializing in medicine, radiation oncology, and pediatric brain tumors.

Top concepts

Publications per year

2006–2021

10

Publications

10

Inactivation of the p53 pathway in retinoblastoma

Nikia A. Laurie, Stacy L. Donovan, Chie-Schin Shih et al. · Nature · 2006 · 585 citations

, , +5

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries

Lindsey M. Hoffman, Sophie E. M. Veldhuijzen van Zanten, Niclas Colditz et al. · Journal of Clinical Oncology · 2018 · 408 citations

, , +23

First-Line Pembrolizumab/Placebo Plus Trastuzumab and Chemotherapy in Her2-Positive Advanced Gastric Cancer: KEYNOTE-811

Hyun Cheol Chung, Yung‐Jue Bang, Charles S. Fuchs et al. · Future Oncology · 2020 · 161 citations · Full text

, , +10

KEYNOTE-975 Study Design: a Phase III Study of Definitive Chemoradiotherapy Plus Pembrolizumab in Patients with Esophageal Carcinoma

Manish A. Shah, Jaafar Bennouna, Toshihiko Doi et al. · Future Oncology · 2021 · 121 citations · Full text

Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10

Zev A. Wainberg, Charles S. Fuchs, Josep Tabernero et al. · Clinical Cancer Research · 2021 · 78 citations · Full text

1–5 of 10